Save your place

Sign in to WhoBought

Please try again later.

Benitec Biopharma Inc. (BNTC) institutional ownership

Latest close $11.97 Jul 20, 2026
Market cap$288M 52-week range SectorHealthcare
Funds holding · Q3 2024
1
reported BNTC position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q3 2024
Activity unavailable N/A
0 buyers · 1 sellers

Benitec Biopharma Inc. (BNTC) price and institutional activity

Dates

Q3 2024

$0 bought by 0 investors
$0 sold by 1 investors
Awm Investment Company, Inc.
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Benitec Biopharma Inc. (BNTC) institutional activity · 1

Investor Type Est. change Change Δ Own Date
Awm Investment Company, Inc. · Exited
Change −625K Δ Own −100.0% Date Q3 2024
Awm Investment Company, Inc. Exited· Q3 2024 −625K −100.0% Q3 2024
Data through Q3 2024 · filed Q3 2024
1 of 1

Famous investor activity in Benitec Biopharma Inc. (BNTC)

Benitec Biopharma Inc. (BNTC) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Buchi J. Kevin · Director Gift (G) -52K
Owned 52K ΔOwn −49.9% Trade date Jun 29, 2026 Filed date Jun 30, 2026
Buchi J. Kevin Director Gift (G) -52K 52K −49.9% Jun 29, 2026 Jun 30, 2026
Friedman David Matthew · Director Grant (A) 35K
Owned 35K Trade date May 26, 2026 Filed date May 28, 2026
Friedman David Matthew Director Grant (A) 35K 35K May 26, 2026 May 28, 2026
Mates Sharon · Director Grant (A) 32K
Owned 32K Trade date Jan 22, 2026 Filed date Jan 26, 2026
Mates Sharon Director Grant (A) 32K 32K Jan 22, 2026 Jan 26, 2026
Cowen Aaron · Director, 10% Owner 2 operations +$1.0M
Price $13.44 Qty +77K Owned 1.8M Trade date Dec 29, 2025 Filed date Dec 29, 2025
Cowen Aaron Director, 10% Owner 2 operations $13.44 +77K +$1.0M 1.8M Dec 29, 2025 Dec 29, 2025
Cowen Aaron · Director, 10% Owner 2 operations +$221K
Price $13.10 Qty +17K Owned 1.8M Trade date Dec 26, 2025 Filed date Dec 29, 2025
Cowen Aaron Director, 10% Owner 2 operations $13.10 +17K +$221K 1.8M Dec 26, 2025 Dec 29, 2025
Cowen Aaron · Director, 10% Owner 2 operations +$642K
Price $12.85 Qty +50K Owned 9.6M Trade date Dec 23, 2025 Filed date Dec 29, 2025
Cowen Aaron Director, 10% Owner 2 operations $12.85 +50K +$642K 9.6M Dec 23, 2025 Dec 29, 2025
Averill Madison Master Fund, Ltd. · 10% Owner 2 operations +$236K
Price $12.08 Qty +20K Owned 1.8M Trade date Dec 22, 2025 Filed date Dec 22, 2025
Averill Madison Master Fund, Ltd. 10% Owner 2 operations $12.08 +20K +$236K 1.8M Dec 22, 2025 Dec 22, 2025
Averill Madison Master Fund, Ltd. · 10% Owner 2 operations +$188K
Price $11.48 Qty +16K Owned 9.6M Trade date Dec 19, 2025 Filed date Dec 22, 2025
Averill Madison Master Fund, Ltd. 10% Owner 2 operations $11.48 +16K +$188K 9.6M Dec 19, 2025 Dec 22, 2025
Averill Madison Master Fund, Ltd. · 10% Owner 2 operations +$115K
Price $11.24 Qty +10K Owned 1.8M Trade date Dec 18, 2025 Filed date Dec 22, 2025
Averill Madison Master Fund, Ltd. 10% Owner 2 operations $11.24 +10K +$115K 1.8M Dec 18, 2025 Dec 22, 2025
Mates Sharon · Director Grant (A) 4K
Owned 4K Trade date Dec 1, 2025 Filed date Dec 3, 2025
Mates Sharon Director Grant (A) 4K 4K Dec 1, 2025 Dec 3, 2025
Mehta Kishan · Director Grant (A) 35K
Owned 35K Trade date Dec 1, 2025 Filed date Dec 3, 2025
Mehta Kishan Director Grant (A) 35K 35K Dec 1, 2025 Dec 3, 2025
Smith Edward F. · Director Grant (A) 35K
Owned 35K Trade date Dec 1, 2025 Filed date Dec 3, 2025
Smith Edward F. Director Grant (A) 35K 35K Dec 1, 2025 Dec 3, 2025
Francis Peter · Director Grant (A) 35K
Owned 35K Trade date Dec 1, 2025 Filed date Dec 3, 2025
Francis Peter Director Grant (A) 35K 35K Dec 1, 2025 Dec 3, 2025
Buchi J. Kevin · Director Grant (A) 35K
Owned 35K Trade date Dec 1, 2025 Filed date Dec 3, 2025
Buchi J. Kevin Director Grant (A) 35K 35K Dec 1, 2025 Dec 3, 2025
Mukadam Sophie · Officer Grant (A) 500K
Owned 500K Trade date Nov 18, 2025 Filed date Nov 20, 2025
Mukadam Sophie Officer Grant (A) 500K 500K Nov 18, 2025 Nov 20, 2025
15 of 19
15 of 19 Sign in to continue to older insider transactions.

Benitec Biopharma Inc. (BNTC) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Suvretta Capital Management, LLC 15.6M
% of shares outstanding 49.9% Filing date Mar 28, 2025
Suvretta Capital Management, LLC 15.6M 49.9% Mar 28, 2025
Franklin Resources Inc 588K
% of shares outstanding 22.9% Filing date Dec 11, 2023
Franklin Resources Inc 588K 22.9% Dec 11, 2023
Suvretta Capital Management, LLC 1.5M
% of shares outstanding 17.4% Filing date Apr 29, 2024
Suvretta Capital Management, LLC 1.5M 17.4% Apr 29, 2024
Janus Henderson Group PLC 2.7M
% of shares outstanding 11.6% Filing date Dec 6, 2024
Janus Henderson Group PLC 2.7M 11.6% Dec 6, 2024
Hbm Healthcare Investments (cayman) Ltd. 850K
% of shares outstanding 10.0% Filing date Apr 29, 2024
Hbm Healthcare Investments (cayman) Ltd. 850K 10.0% Apr 29, 2024
Adage Capital Partners Gp, L.L.C. 265K
% of shares outstanding 10.0% Filing date Apr 11, 2024
Adage Capital Partners Gp, L.L.C. 265K 10.0% Apr 11, 2024
Oliveira Steven Michael 746K
% of shares outstanding 8.4% Filing date Apr 29, 2024
Oliveira Steven Michael 746K 8.4% Apr 29, 2024
Cvi Investments, Inc. 1.5M
% of shares outstanding 4.9% Filing date Feb 14, 2023
Cvi Investments, Inc. 1.5M 4.9% Feb 14, 2023
8 of 13

Benitec Biopharma Inc. (BNTC) ownership FAQ

Who owns BNTC?

1 reporting institutions disclosed BNTC position changes in the Q3 2024 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q3 2024.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.